Results 311 to 320 of about 514,735 (343)
Some of the next articles are maybe not open access.

The Immunosuppressed Traveler

Infectious Disease Clinics of North America, 2012
This article reviews the normal immune response to vaccines. It describes the effect of different immunosuppressive therapies (glucocorticoids, inhibitors of calcineurin and mTOR, azathioprine, mycophenolate acid, methotrexate, depleting and nondepleting monoclonal antibodies, and tumor necrosis factor antagonists) on critical steps in the cellular and
openaire   +3 more sources

Immunosuppression on the Horizon [PDF]

open access: possibleHeart Failure Clinics, 2007
Many novel immunosuppressive agents are under active clinical investigation. In addition, creative approaches are being developed for the use of established immunosuppressive agents, with the goal of minimizing immunosuppression as early as possible posttransplantation.
openaire   +2 more sources

Porokeratosis and immunosuppression

British Journal of Dermatology, 1995
Immunosuppression may favour the development of disseminated superficial porokeratosis (DSP). We report the clinical features and the outcome of DSP in 24 patients receiving immunosuppressive treatment (group A), and compare the characteristics of the disease with those of 13 immunocompetent patients with DSP (group B). The two groups were similar with
Ruggero Caputo   +4 more
openaire   +3 more sources

Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression

Advances in Materials, 2020
Effective reversal of tumor immunosuppression is of critical importance in cancer therapy. A multifunctional delivery vector that can effectively deliver CRISPR‐Cas9 plasmid for β‐catenin knockout to reverse tumor immunosuppression is constructed.
Xiao-Yan He   +7 more
semanticscholar   +1 more source

Principles of Immunosuppression

Critical Care Clinics, 1990
One-year graft survival rates of 80% to 90% can now be achieved routinely for primary cadaveric transplants with a variety of CSA-containing regimens. Further improvement of these excellent results may be difficult because large numbers of patients must be evaluated to provide meaningful conclusions.
Daniel M. Canafax   +3 more
openaire   +3 more sources

Immunosuppression—An overview

Seminars in Veterinary Medicine and Surgery: Small Animal, 1997
The therapy of immune-mediated diseases in dogs and cats requires effective immunosuppressive therapy. The ideal therapy would suppress the abnormal (anti-self) immune responses while leaving the normal (anti-pathogen) immune responses intact. Unfortunately, such a therapy is not readily available.
openaire   +3 more sources

[Pharmacogenetics of immunosuppressants].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2015
Individualized drug therapy with immunosuppressants is an hot topic in transplantation. Therapeutic drug monitoring (TDM) is currently utilized to guide therapy, but toxic or subtherapeutic concentrations can only be identified after the drug is administered.
Cojutti P. G., Baraldo M.
openaire   +3 more sources

Immunosuppressive therapy

Current Opinion in Immunology, 1992
Although Cyclosporin A has improved transplant outcome, its use has serious limitations due to its narrow therapeutic window. New approaches to broaden this window exploit alternative drug formulations, pharmacokinetic profiling and new immunosuppressive agents, such as Rapamycin and Brequinar, which act in a synergistic fashion.
openaire   +2 more sources

Mechanisms of immunosuppression

Veterinary Immunology and Immunopathology, 1991
Immunosuppresive disease is a major economic concern in domestic poultry production. Although many immunosuppressive agents have been described, mechanisms of how infectious and noninfectious agents compromise the immune system are poorly understood in avian species. Two categories, generalized and antigen-specific immunosuppression have been described
openaire   +3 more sources

Home - About - Disclaimer - Privacy